Cambrex Tillotts form agreement proprietary technology usage

Cambrex and Tillotts form agreement for proprietary technology usage

4:02 PM, 7th July 2011
Cambrex and Tillotts form agreement for proprietary technology usage

Tillotts has entered into a development and commercialization agreement for proprietary 5-ASA-based technology. 

EAST RUTHERFORD, US/RHEINFELDEN, SWITZERLAND: Cambrex Corporation and Tillotts Pharma AG have entered into a development and commercialization agreement for a proprietary mesalamine-based (5-ASA) technology for use in the treatment of inflammatory bowel disease (IBD).

“This deal, which gives Tillotts worldwide access to an exciting proprietary 5-ASA-based technology, is an additional important step in our forceful efforts to build an attractive and innovative gastrointestinal product portfolio, complementary to our Asacol and Colpermin,” commented Thomas A Toth von Kisker, President and CEO, Tillotts.

Under the terms of the agreement, Tillotts has acquired from Cambrex worldwide exclusive rights to develop and commercialize drug products based on the proprietary 5-ASA-based technology in exchange for developmental, regulatory and IP milestone payments as well as royalties. Cambrex previously acquired the exclusive rights to this technology from PLx Pharma Inc (Houston, TX).

“Today’s announcement serves as a prime example of Cambrex’s commitment to accelerating our customers’ drug development processes. It further underscores our goal to being a leading player in the development and supply of mesalamine-based active ingredients,” said Steven M Klosk, President and CEO, Cambrex.

© WOC News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

MEMC and Jusung partner to build new production facility

  GEYONGGI-DO, KOREA/ST PETERS, US: MEMC Singapore Pte Ltd, an affiliate of MEMC Electronic Materials Inc and Jusung Engineering Co Ltd, announc ...

Read more
A novel enzymatic catalyst for biodiesel production

PARIS, FRANCE: Continuous production of biodiesel can now be envisaged thanks to a novel catalyst developed by a team at CNRS’s Centre de Recher ...

Read more
China to ban 10 highly toxic insecticides

BEIJING, CHINA: The government of China plans to ban 10 types of high toxic insecticides by year end in an effort to ensure farm produce safety and pr ...

Read more
WTO rules against China on limiting export of raw materials

GENEVA, SWITZERLAND: The World Trade Organization ruled that China was unfairly protecting its domestic manufacturers by limiting the export of nine r ...

Read more
Tokyo Institute of Technology professor bags Humboldt Research award

TOKYO, JAPAN: Professor Takao Ikariya of the Department of Applied Chemistry, Graduate School of Engineering is to be honoured with the Humboldt Resea ...

Read more
Liquid cement turns liquid metal

TOKYO, JAPAN: Concrete is heavy, tough and - you might think - a reliable insulator. But researchers in Japan have shown that, by doping it with free ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X